In: Obesity Facts, 2014, vol. 7, no. 1, p. 15–25
The concept of energy gap(s) is useful for understanding the consequence of a small daily, weekly, or monthly positive energy balance and the inconspicuous shift in weight gain ultimately leading to overweight and obesity. Energy gap is a dynamic concept: an initial positive energy gap incurred via an increase in energy intake (or a decrease in physical activity) is not constant, may fade out...
|
In: Cahiers de Nutrition et de Diététique, 2013, vol. 48, no. 1, p. 15–25
Le titre d’un livre publié en 1983 ‘Dieting Makes You Fat’ – concrétise la notion que faire un régime pour contrôler son poids, et par conséquent l’effet yo-yo, prédispose l’individu à être encore plus gras. Alors que cette notion est controversée, son débat souligne le fossé qui existe dans notre compréhension des lois fondamentales de la physiologie qui gouvernent la...
|
In: International Journal of Obesity, 2012, vol. 36, p. 1418–1420
|
In: Proceedings of the Nutrition Society, 2012, p. -
|
In: Obesity Reviews, 2011, vol. 12, no. 7, p. e573–e581
Different outcomes of the effect of catechin-caffeine mixtures and caffeine-only supplementation on energy expenditure and fat oxidation have been reported in short-term studies. Therefore, a meta-analysis was conducted to elucidate whether catechin-caffeine mixtures and caffeine-only supplementation indeed increase thermogenesis and fat oxidation. First, English-language studies measuring daily...
|
In: Diabetes, 2009, vol. 58, no. 5, p. 1037-1039
|
In: American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 2008, vol. 294, p. R730-R737
Brown, Clive M.; Division of Physiology, Department of Medicine, University of Fribourg, Switzerland Dulloo, Abdul G.; Division of Physiology, Department of Medicine, University of Fribourg, Switzerland Yepuri, Gayathri; Division of Physiology, Department of Medicine, University of Fribourg, Switzerland Montani, and Jean-Pierre; Division of Physiology, Department of Medicine, University of...
|
In: International Journal of Obesity, 2007, vol. 31, no. 2, p. 201-203
|
In: British Journal of Nutrition, 2007, vol. 93, p. 417-419
|
In: American Journal of Physiology - Endocrinology and Metabolism, 2007, vol. 293, p. E91-E95
Glitazones are peroxisome proliferator-activated receptor (PPAR)-Γ agonists with powerful insulin-sensitizing properties. They promote the development of metabolically active adipocytes that can lead to a substantial gain in fat mass. Telmisartan is an ANG II type 1 receptor antagonist with partial PPAR-Γ agonistic properties. Recently, telmisartan has been reported to prevent weight gain and...
|